worried data hidden clinical trials negative data regarding drug safety efficacy buried worry longer least super optimistic authors new england journal medicine would believe wrote special interest additional provision requires sponsors clinically directive therapeutic trials register studies inception public database sponsored national library medicine although aspects provision ideal delayed public availability registration information device trials noninclusion phase trials mandatory registration represents critical advance making clinical trials new treatments public knowledge decade ago clinical trial could conducted secret trial sponsor claiming proprietary rights could keep information including existence private thus drug important adverse effects information might never made public legislators believed possibility best interests american people clinical trial mounted sponsor ethical obligation publicly acknowledge contribution participants risk taken ensuring information conduct trial principal results public domain fda revitalization united states joins countries recognizing human volunteers needed complete trial precious money required mount wow everything looking data reported well i read i think relatively updated version said legislation i really see anything requires results reported every trial nothing even close described unless i missed something data reporting requirements pretty simple data every single efficacy safety measure must reported full nothing less acceptable otherwise sponsors continue fund research positive data reported negative data minimized present system broken example present clinical trials database close useless learning study results first come snippets registered clinical trial comes publication based upon results snippets trial protocol going happen study study effectiveness adding abilify aripiprazole atypical antipsychotic medication ongoing ssri antidepressant treatment depressed outpatients responding fully ssri treatment alone hypothesized patients functioning improve weeks treatment aripiprazole ssri medication total enrollment primary outcome measures hamilton depression rating scale hdrs secondary outcome measures clinical global impressions scale cgi global assessment functioning scale gafs beck depression inventory bdi study chairs principal investigators david hellerstein md principal investigator ny state psychiatric institute st luke roosevelt hospital center publications hellerstein dj aripiprazole adjunctive treatment refractory major depression prog neuropsychopharmacol biol psychiatry dec abstract available clinical trial entry vs publication see details patients enrolled study using four measures outcome let see cited publication say results ms v year old single female year history severe depression patients point venlafaxine mirtazapine working aripiprazole added initially mg day increased mg day within month ms v noted mood concentration improved longer anhedonic began socializing family members began gardening able concentrate reading movies months venlafaxine extended release mirtazapine aripiprazole ms v noted appetite remained good sleeping per night mood much better begun seek new job sending resumes phoning prospective employers happened measures outcome mentioned linked publication discusses one case though trial study people jump bridge happened going clinical trial registry requires reporting results want i hope next obligatory pro abilify propaganda furthermore aripiprazole benign side effect profile including minimal weight gain sedation parkinsonism resulting low affinity alpha adrenergic histamine muscarinic receptors suggests may tolerable refractory depressed patients may need adjunctive treatment long period time case ms v suggests possible benefit aripiprazole treatment resistant depression adjunct antidepressant medications clinical trial data support discussion one always fall back discussing various receptors theoretically tweaking one way another going lead positive results case study ends studies aripiprazole adjunctive medication treatment resistant depression indicated yeah happened patients study i search medline find additional studies hellerstein using abilify depression i could find nothing seemed fit bill please alert me i missed something search one could argue perhaps study midst written publication sure taking i time i go clinicaltrials gov registry i sure i find interesting discrepancies clinical trial protocols researchers say going happen actually published official record actually happened fact i done i noted published study risperdal depression clearly changed data reporting somewhere clinical trial registry eventual publication rather thorough investigation topic found overall efficacy harm outcomes per trial incompletely reported statistically significant outcomes higher odds fully reported compared nonsignificant outcomes efficacy pooled odds ratio confidence interval ci harm pooled odds ratio ci data comparing published articles protocols trials least primary outcome changed introduced omitted eighty six percent survey responders denied existence unreported outcomes despite clear evidence contrary cares well mind receiving part efficacy safety data anything send emails tell none friends bother local journal editor ask doctor aware called bedrock evidence based medicine i results published scientific journals based selectively reported information kool aid i really stunned folks new england journal medicine would rush publish essay great things going people calling data shared openly quite time magically passing vague legislation data made publicly available drug industry suddenly going publish information clinical trials overnight bigwigs nejm willing drink kool aid pathetic